Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor-type specific methylation patterns of MTAP in human samples and cell lines.

Clinical epigenetics·2026
Same author

hexABC seeking the physical code of DNA.

Nature communications·2026
Same author

From trial-and-error to inverse design: how AI is redefining drug delivery systems.

Drug discovery today·2026
Same author

Cooperative molecular interaction networks govern PARP1 inhibitor selectivity and binding affinity.

PLoS computational biology·2026
Same author

Correction to: Rational design of lipid-based nanoparticles for targeted anticancer therapies.

Drug delivery and translational research·2026
Same author

Guanidine-Based Ligands in Bioinorganic Chemistry: Coordination Modes and Applications in Anticancer Metallodrugs.

Bioinorganic chemistry and applications·2026

Related Experiment Video

Updated: Jun 16, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

15.7K

Comparative Assessment of Free Energy Computational Methods for Revealing the Interactions Driving PARP1 Selective

Alejandro Feito1,2, Natàlia DeMoya-Valenzuela3, Cristian Privat3

  • 1Department of Physical Chemistry, Universidad Complutense de Madrid, Av. Complutense s/n, Madrid 28040, Spain.

Journal of Chemical Information and Modeling
|April 18, 2026
PubMed
Summary

Predicting drug selectivity between similar proteins like PARP1 and PARP2 is difficult. Absolute Binding Free Energy (ABFE) calculations accurately predict inhibitor selectivity, offering insights for precision oncology drug design.

More Related Videos

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.4K
A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

10.7K

Related Experiment Videos

Last Updated: Jun 16, 2026

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
15:53

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

15.7K
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.4K
A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
10:28

A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors

Published on: August 17, 2019

10.7K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Structural biology

Background:

  • Accurate prediction of inhibitor selectivity across protein paralogues is crucial for drug discovery.
  • PARP enzyme inhibitors are vital for treating various cancers, including ovarian, breast, and prostate tumors.

Purpose of the Study:

  • To comparatively assess three computational methods (MM/PBSA, ABFE, and US) for predicting PARP1 versus PARP2 inhibitor selectivity.
  • To evaluate the ability of these methods to recapitulate experimental binding affinities for eight clinically relevant PARP inhibitors.

Main Methods:

  • Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA) calculations.
  • Absolute Binding Free Energy (ABFE) calculations.
  • Umbrella Sampling (US) calculations with atomistic models and explicit solvent.

Main Results:

  • MM/PBSA provides rapid insights but is sensitive to conformational poses, challenging for subtle energetic differences.
  • ABFE and US calculations show improved agreement with experimental binding affinities.
  • ABFE demonstrated the strongest quantitative correlation with experimental binding free energy differences, accurately reproducing selectivity trends.

Conclusions:

  • ABFE and US calculations offer reliable predictions of inhibitor selectivity, outperforming MM/PBSA.
  • Structural contact analysis provides mechanistic insights into ligand selectivity and identifies key stabilizing residues.
  • This study informs the design of more potent and specific inhibitors for precision oncology, particularly for homologous recombination-deficient cancers.